| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Processa Pharmaceuticals, Inc. (PCSA) has 10 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. PCSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 100.0K | $208.0K | - | |
| ? | 100.0K | $208.0K | - | |
| ? | 100.0K | $208.0K | - | |
| ? | 100.0K | $208.0K | - | |
| Other | 96.0K | $199.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Lin Patrick | Chief Business - Strategy Off | Buy | 43,500 | $0.80 | $34,691.25 | New | -61.5% | -79.1% | |
| Jan 27, 2025 | Yorke Justin W56 | - | Buy | 12,400 | $0.80 | $9,889.00 | New | -61.5% | -79.1% | |
| Feb 7, 2024 | Young David | Pres. Research &Development | Buy | 21,000 | $2.45 | $51,525.60 | +36.0% | +11.2% | -73.3% | |
| Feb 6, 2024 | Young David | Pres. Research &Development | Buy | 20,000 | $2.53 | $50,504.00 | +52.1% | -1.3% | -74.8% | |
| Feb 1, 2024 | Lin Patrick | Chief Business - Strategy Off | Buy | 4,000 | $2.38 | $9,525.00 | +8.1% | -5.1% | -72.2% | |
| Jan 30, 2024 | Yorke Justin W56 | - | Buy | 8,000 | $2.69 | $21,544.00 | +34.4% | -22.2% | -78.1% | |
| Jan 30, 2024 | Ng George K | Chief Executive Officer | Buy | 10,000 | $2.70 | $27,000.00 | +100.0% | -22.2% | -78.1% | |
| Jun 12, 2023 | Young David | President &CEO | Buy | 40,000 | $0.80 | $32,000.00 | +9.3% | -60.3% | -87.7% | |
| Apr 14, 2023 | Young David | President &CEO | Buy | 20,000 | $0.55 | $10,998.00 | +4.9% | -2.5% | -83.3% | |
| Apr 13, 2023 | Young David | President &CEO | Buy | 60,000 | $0.48 | $29,000.00 | +5.4% | +6.3% | -82.2% |